*The Role of the DNA Damage Response in Ataxia-Telangiectasia Syndrome DOI: http://dx.doi.org/10.5772/intechopen.84902*

et al. Identification of a functional domain in a GADD45-mediated G2/M checkpoint. The Journal of Biological Chemistry. 2000

*Neurodevelopment and Neurodevelopmental Disorder*

[63] Xiao Z, Chen Z, Gunasekera AH, Sowin TJ, Rosenberg SH, Fesik S, et al. Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents. The Journal of

Biological Chemistry. 2003

[64] Mailand N, Falck J, Lukas C,

Syljuåsen RG, Welcker M, Bartek J, et al. Rapid destruction of human Cdc25A in response to DNA damage. Science. 2000

[65] Abbas T, Dutta A. P21 in cancer: Intricate networks and multiple

activities. Nature Reviews. Cancer. 2009

[68] Sanchez Y, Bachant J, Wang H, Hu F, Liu D, Tetzlaff M, et al. Control of the DNA damage checkpoint by Chk1 and Rad53 protein kinases through distinct

[66] Bartek J, Lukas J. Chk1 and Chk2 kinases in checkpoint control and

cancer. Cancer Cell. 2003

mechanisms. Science. 1999

[69] Sanchez Y, Wong C, Thoma RS, Richman R, Wu Z, Piwnica-Worms H, et al. Conservation of the Chk1 checkpoint pathway in mammals: Linkage of DNA damage to Cdk

regulation through Cdc25. Science. 1997

[70] Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS, Piwnica-Worms H. Mitotic and G2 checkpoint control: Regulation of 14-3-3 protein binding by phosphorylation of Cdc25c on

[71] Lee J, Kumagai A, Dunphy WG. Positive regulation of Wee1 by Chk1 and 14-3-3 proteins. Molecular Biology of

[72] Yang Q, Manicone A, Coursen JD, Linke SP, Nagashima M, Forgues M,

serine-216. Science. 1997

the Cell. 2001

[67] Liu S, Shiotani B, Lahiri M, Maréchal A, Tse A, Leung CCY, et al. ATR autophosphorylation as a molecular switch for checkpoint activation. Molecular Cell. 2011

et al. ATR-dependent phosphorylation of FANCA on serine 1449 after DNA damage is important for FA pathway

[55] Ceccaldi R, Sarangi P, D'Andrea AD. The Fanconi anaemia pathway: New players and new functions. Nature Reviews. Molecular Cell Biology. 2016

[56] Offer H, Zurer I, Banfalvi G, Reha'K M, Falcovitz A, Milyavsky M, et al. p53 modulates base excision repair activity in a cell cycle-specific manner after genotoxic stress. Cancer Research. 2001

[57] Zurer I, Hofseth LJ, Cohen Y, Xu-Welliver M, Hussain SP, Harris CC, et al. The role of p53 in base excision repair following genotoxic stress.

Carcinogenesis. 2004

2004

Journal. 2010

[58] Romanova LY, Willers H, Blagosklonny MV, Powell SN. The interaction of p53 with replication protein a mediates suppression of homologous recombination. Oncogene.

[59] Ammazzalorso F, Pirzio LM, Bignami M, Franchitto A, Pichierri P. ATR and ATM differently regulate WRN to prevent DSBs at stalled replication forks and promote replication fork recovery. The EMBO

[60] Croteau DL, Popuri V, Opresko PL, Bohr VA. Human RecQ helicases in DNA repair, recombination, and replication. Annual Review of Biochemistry. 2014

checkpoint signaling through the ATR and ATM kinases. In: 2nd International Conference on Information Science and Engineering, ICISE2010 – Proceedings;

[62] Bartek J, Lukas J. Mammalian G1 and S-phase checkpoints in response to DNA damage. Current Opinion in Cell

[61] Liu M, Hu WX. Cell cycle

function. Blood. 2009

**82**

Biology. 2001

2010

[73] Harvey SL, Charlet A, Haas W, Gygi SP, Kellogg DR. Cdk1-dependent regulation of the mitotic inhibitor Wee1. Cell. 2005

[74] Zitouni S, Nabais C, Jana SC, Guerrero A, Bettencourt-Dias M. Pololike kinases: Structural variations lead to multiple functions. Nature Reviews. Molecular Cell Biology. 2014

[75] Mackay DR, Ullman KS. ATR and a Chk1-Aurora B pathway coordinate postmitotic genome surveillance with cytokinetic abscission. Molecular Biology of the Cell. 2015

[76] Christmann M, Kaina B. Transcriptional regulation of human DNA repair genes following genotoxic stress: Trigger mechanisms, inducible responses and genotoxic adaptation. Nucleic Acids Research. 2013

[77] Adimoolam S, Ford JM. p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene. Proceedings of the National Academy of Sciences. 2002

[78] Jenkins LMM, Durell SR, Mazur SJ, Appella E. p53 N-terminal phosphorylation: A defining layer of complex regulation. Carcinogenesis. 2012

[79] Gannon HS, Woda BA, Jones SN. ATM phosphorylation of Mdm2 Ser394 regulates the amplitude and duration of the DNA damage response in mice. Cancer Cell. 2012

[80] Vousden KH, Lane DP. p53 in health and disease. Nature Reviews. Molecular Cell Biology. 2007

[81] Nakano K, Vousden KH. PUMA, a novel proapoptotic gene, is induced by p53. Molecular Cell. 2001

[82] Wu Y, Mehew JW, Heckman CA, Arcinas M, Boxer LM. Negative regulation of bcl-2 expression by p53 in hematopoietic cells. Oncogene. 2001

[83] Shimizu I, Yoshida Y, Suda M, Minamino T. DNA damage response and metabolic disease. Cell Metabolism. 2014

[84] Jackson JG, Pereira-Smith OM. p53 is preferentially recruited to the promoters of growth arrest genes p21 and GADD45 during replicative senescence of normal human fibroblasts. Cancer Research. 2006

[85] Elledge SJ, Zhou Z, Allen JB, Navas TA. DNA damage and cell cycle regulation of ribonucleotide reductase. BioEssays. 1993

[86] Chabes A, Georgieva B, Domkin V, Zhao X, Rothstein R, Thelander L. Survival of DNA damage in yeast directly depends on increased dNTP levels allowed by relaxed feedback inhibition of ribonucleotide reductase. Cell. 2003

[87] Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Fukuda S, Matsui K, et al. A ribonucleotide reductase gene involved in a p53 dependent cell-cycle checkpoint for DNA damage. Nature. 2000

[88] de Lange T. Shelterin-mediated telomere protection. Annual Review of Genetics. 2018

[89] Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, Saretzki G, et al. A DNA damage checkpoint response in telomereinitiated senescence. Nature. 2003

[90] Abedin MJ, Wang D, McDonnell MA, Lehmann U, Kelekar A. Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death and Differentiation. 2007

[91] Zhang J, Tripathi DN, Jing J, Alexander A, Kim J, Powell RT, et al. ATM functions at the peroxisome to induce pexophagy in response to ROS. Nature Cell Biology. 2015

[92] Valentin-Vega YA, Kastan MB. A new role for ATM: Regulating mitochondrial function and mitophagy. Autophagy. 2012

[93] Valentin-Vega YA, MacLean KH, Tait-Mulder J, Milasta S, Steeves M, Dorsey FC, et al. Mitochondrial dysfunction in ataxia-telangiectasia. Blood. 2012

[94] Zaki-Dizaji M, Akrami SM, Azizi G, Abolhassani H, Aghamohammadi A. Inflammation, a significant player of ataxia–telangiectasia pathogenesis? Inflammation Research. 2018

[95] Hellweg CE. The nuclear factor κB pathway: A link to the immune system in the radiation response. Cancer Letters. 2015

[96] Hadian K, Krappmann D, Hayden MS, Ghosh S, Vallabhapurapu S, Karin M, et al. Signals from the nucleus: Activation of NF-kappaB by cytosolic ATM in the DNA damage response. Science Signaling. 2011

[97] Stilmann M, Hinz M, Arslan SÇ, Zimmer A, Schreiber V, Scheidereit C. A nuclear poly[ADP-ribose]-dependent signalosome confers DNA damageinduced IκB kinase activation. Molecular Cell. 2009

[98] Miyamoto S. Nuclear initiated NF-κB signaling: NEMO and ATM take center stage. Cell Research. 2011

[99] Kang C, Xu Q, Martin TD, Li MZ, Demaria M, Aron L, et al. The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4. Science. 2015

[100] Zaki-Dizaji M, Akrami SM, Abolhassani H, Rezaei N, Aghamohammadi A. Ataxia

telangiectasia syndrome: Moonlighting ATM. Expert Review of Clinical Immunology. 2017

[101] Chun HH, Gatti RA. Ataxiatelangiectasia, an evolving phenotype. DNA Repair. 2004

[102] Verhagen MMM, Abdo WF, Willemsen MAAP, Hogervorst FBL, Smeets DFCM, Hiel JAP, et al. Clinical spectrum of ataxia-telangiectasia in adulthood. Neurology. 2009

[103] Taylor AMR, Harnden DG, Arlett CF, Harcourt SA, Lehmann AR, Stevens S, et al. Ataxia telangiectasia: A human mutation with abnormal radiation sensitivity. Nature. 1975

[104] Ammann AJ, Hong R. Autoimmune phenomena in ataxia telangiectasia. The Journal of Pediatrics. 1971

[105] Verhagen MMM, Last JI, Hogervorst FBL, Smeets DFCM, Roeleveld N, Verheijen F, et al. Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: A genotypephenotype study. Human Mutation. 2012

[106] Biton S, Barzilai A, Shiloh Y. The neurological phenotype of ataxiatelangiectasia: Solving a persistent puzzle. DNA Repair (Amst). 2008

[107] Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, et al. Atm-deficient mice: A paradigm of ataxia telangiectasia. Cell. 1996

[108] Elson A, Wang Y, Daugherty CJ, Morton CC, Zhou F, Campos-Torres J, et al. Pleiotropic defects in ataxiatelangiectasia protein-deficient mice. Proceedings of the National Academy of Sciences. 1996

[109] Xu Y, Ashley T, Brainerd EE, Bronson RT, Meyn MS, Baltimore D. Targeted disruption of ATM leads to growth retardation, chromosomal

**85**

2009

Cell. 2012

*The Role of the DNA Damage Response in Ataxia-Telangiectasia Syndrome*

[118] Tresini M, Warmerdam DO, Kolovos P, Snijder L, Vrouwe MG, Demmers JAA, et al. The core spliceosome as target and effector of non-canonical ATM signalling. Nature.

[119] Kamiya M, Yamanouchi H, Yoshida T, Arai H, Yokoo H, Sasaki A, et al. Ataxia telangiectasia with vascular abnormalities in the brain parenchyma: Report of an autopsy case and literature review. Pathology International. 2001

[120] Schoenaker MHD, Van Os NJH, Van der Flier M, Van Deuren M, Seyger MM, Taylor AMR, et al. Telangiectasias

in ataxia telangiectasia: Clinical significance, role of ATM deficiency and potential pathophysiological mechanisms. European Journal of

[121] Kuilman T, Michaloglou C, Vredeveld LCW, Douma S, van Doorn R, Desmet CJ, et al. Oncogene-induced senescence relayed by an interleukindependent inflammatory network. Cell.

[122] Acosta JC, O'Loghlen A, Banito A, Guijarro MV, Augert A, Raguz S, et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell.

[123] Driessen GJ, Ijspeert H, Weemaes CMR, Haraldsson Á, Trip M, Warris A, et al. Antibody deficiency in patients with ataxia telangiectasia is caused by disturbed B- and T-cell homeostasis and reduced immune repertoire diversity. The Journal of Allergy and Clinical

[124] Nowak-Wegrzyn A, Crawford TO, Winkelstein JA, Carson KA, Lederman HM. Immunodeficiency and infections in ataxia-telangiectasia. Journal of

[125] Bassing CH, Swat W, Alt FW. The mechanism and regulation of

Medical Genetics. 2018

2008

2008

Immunology. 2013

Pediatrics. 2004

2015

*DOI: http://dx.doi.org/10.5772/intechopen.84902*

fragmentation during meiosis, immune defects, and thymic lymphoma. Genes

Shigenaga MK, Smith MA, Morrow JD, Roberts LJ, et al. Loss of the ataxia– telangiectasia gene product causes oxidative damage in target organs.

[111] Kamsler A, Daily D, Hochman A, Stern N, Shiloh Y, Rotman G, et al. Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from ATMdeficient mice. Cancer Research. 2001

[112] Weissman L, de Souza-Pinto NC, Stevnsner T, Bohr VA. DNA repair, mitochondria, and neurodegeneration.

[113] Rutten BPF, Schmitz C, Gerlach OHH, Oyen HM, de Mesquita EB, Steinbusch HWM, et al. The aging brain: Accumulation of dna damage or neuron loss? Neurobiology of Aging. 2007

[114] Stern N, Hochman A, Zemach N, Weizman N, Hammel I, Shiloh Y, et al. Accumulation of DNA damage and reduced levels of nicotine adenine dinucleotide in the brains of ATMdeficient mice. The Journal of Biological

[115] Yang Y, Hui CW, Li J, Herrup K. The interaction of the ATM genotype with inflammation and oxidative stress.

[116] Lee Y, Katyal S, Li Y, El-Khamisy SF, Russell HR, Caldecott KW, et al. The genesis of cerebellar interneurons and the prevention of neural DNA damage require XRCC1. Nature Neuroscience.

[117] Aguilera A, García-Muse T. R loops: From transcription byproducts to threats to genome stability. Molecular

& Development. 1996

Neurobiology. 1999

Neuroscience. 2007

Chemistry. 2002

PLoS One. 2014

[110] Barlow C, Dennery PA,

*The Role of the DNA Damage Response in Ataxia-Telangiectasia Syndrome DOI: http://dx.doi.org/10.5772/intechopen.84902*

fragmentation during meiosis, immune defects, and thymic lymphoma. Genes & Development. 1996

*Neurodevelopment and Neurodevelopmental Disorder*

telangiectasia syndrome: Moonlighting ATM. Expert Review of Clinical

[101] Chun HH, Gatti RA. Ataxiatelangiectasia, an evolving phenotype.

[102] Verhagen MMM, Abdo WF, Willemsen MAAP, Hogervorst FBL, Smeets DFCM, Hiel JAP, et al. Clinical spectrum of ataxia-telangiectasia in

adulthood. Neurology. 2009

Journal of Pediatrics. 1971

[105] Verhagen MMM, Last JI, Hogervorst FBL, Smeets DFCM, Roeleveld N, Verheijen F, et al. Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: A genotypephenotype study. Human Mutation. 2012

[103] Taylor AMR, Harnden DG, Arlett CF, Harcourt SA, Lehmann AR, Stevens S, et al. Ataxia telangiectasia: A human mutation with abnormal radiation sensitivity. Nature. 1975

[104] Ammann AJ, Hong R. Autoimmune phenomena in ataxia telangiectasia. The

[106] Biton S, Barzilai A, Shiloh Y. The neurological phenotype of ataxiatelangiectasia: Solving a persistent puzzle. DNA Repair (Amst). 2008

[107] Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, et al. Atm-deficient mice: A paradigm of ataxia telangiectasia. Cell. 1996

[108] Elson A, Wang Y, Daugherty CJ, Morton CC, Zhou F, Campos-Torres J, et al. Pleiotropic defects in ataxiatelangiectasia protein-deficient mice. Proceedings of the National Academy of

[109] Xu Y, Ashley T, Brainerd EE, Bronson RT, Meyn MS, Baltimore D. Targeted disruption of ATM leads to growth retardation, chromosomal

Sciences. 1996

Immunology. 2017

DNA Repair. 2004

ATM functions at the peroxisome to induce pexophagy in response to ROS. Nature Cell Biology. 2015

[92] Valentin-Vega YA, Kastan MB. A new role for ATM: Regulating

[93] Valentin-Vega YA, MacLean KH, Tait-Mulder J, Milasta S, Steeves M, Dorsey FC, et al. Mitochondrial dysfunction in ataxia-telangiectasia.

Autophagy. 2012

Blood. 2012

Letters. 2015

mitochondrial function and mitophagy.

[94] Zaki-Dizaji M, Akrami SM, Azizi G, Abolhassani H, Aghamohammadi A. Inflammation, a significant player of ataxia–telangiectasia pathogenesis? Inflammation Research. 2018

[95] Hellweg CE. The nuclear factor κB pathway: A link to the immune system in the radiation response. Cancer

Hayden MS, Ghosh S, Vallabhapurapu S, Karin M, et al. Signals from the nucleus: Activation of NF-kappaB by cytosolic ATM in the DNA damage response.

[97] Stilmann M, Hinz M, Arslan SÇ, Zimmer A, Schreiber V, Scheidereit C. A nuclear poly[ADP-ribose]-dependent signalosome confers DNA damageinduced IκB kinase activation.

[98] Miyamoto S. Nuclear initiated NF-κB signaling: NEMO and ATM take center stage. Cell Research. 2011

[99] Kang C, Xu Q, Martin TD, Li MZ, Demaria M, Aron L, et al. The DNA damage response induces inflammation and senescence by inhibiting autophagy

[96] Hadian K, Krappmann D,

Science Signaling. 2011

Molecular Cell. 2009

of GATA4. Science. 2015

[100] Zaki-Dizaji M, Akrami SM, Abolhassani H, Rezaei N, Aghamohammadi A. Ataxia

**84**

[110] Barlow C, Dennery PA, Shigenaga MK, Smith MA, Morrow JD, Roberts LJ, et al. Loss of the ataxia– telangiectasia gene product causes oxidative damage in target organs. Neurobiology. 1999

[111] Kamsler A, Daily D, Hochman A, Stern N, Shiloh Y, Rotman G, et al. Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from ATMdeficient mice. Cancer Research. 2001

[112] Weissman L, de Souza-Pinto NC, Stevnsner T, Bohr VA. DNA repair, mitochondria, and neurodegeneration. Neuroscience. 2007

[113] Rutten BPF, Schmitz C, Gerlach OHH, Oyen HM, de Mesquita EB, Steinbusch HWM, et al. The aging brain: Accumulation of dna damage or neuron loss? Neurobiology of Aging. 2007

[114] Stern N, Hochman A, Zemach N, Weizman N, Hammel I, Shiloh Y, et al. Accumulation of DNA damage and reduced levels of nicotine adenine dinucleotide in the brains of ATMdeficient mice. The Journal of Biological Chemistry. 2002

[115] Yang Y, Hui CW, Li J, Herrup K. The interaction of the ATM genotype with inflammation and oxidative stress. PLoS One. 2014

[116] Lee Y, Katyal S, Li Y, El-Khamisy SF, Russell HR, Caldecott KW, et al. The genesis of cerebellar interneurons and the prevention of neural DNA damage require XRCC1. Nature Neuroscience. 2009

[117] Aguilera A, García-Muse T. R loops: From transcription byproducts to threats to genome stability. Molecular Cell. 2012

[118] Tresini M, Warmerdam DO, Kolovos P, Snijder L, Vrouwe MG, Demmers JAA, et al. The core spliceosome as target and effector of non-canonical ATM signalling. Nature. 2015

[119] Kamiya M, Yamanouchi H, Yoshida T, Arai H, Yokoo H, Sasaki A, et al. Ataxia telangiectasia with vascular abnormalities in the brain parenchyma: Report of an autopsy case and literature review. Pathology International. 2001

[120] Schoenaker MHD, Van Os NJH, Van der Flier M, Van Deuren M, Seyger MM, Taylor AMR, et al. Telangiectasias in ataxia telangiectasia: Clinical significance, role of ATM deficiency and potential pathophysiological mechanisms. European Journal of Medical Genetics. 2018

[121] Kuilman T, Michaloglou C, Vredeveld LCW, Douma S, van Doorn R, Desmet CJ, et al. Oncogene-induced senescence relayed by an interleukindependent inflammatory network. Cell. 2008

[122] Acosta JC, O'Loghlen A, Banito A, Guijarro MV, Augert A, Raguz S, et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell. 2008

[123] Driessen GJ, Ijspeert H, Weemaes CMR, Haraldsson Á, Trip M, Warris A, et al. Antibody deficiency in patients with ataxia telangiectasia is caused by disturbed B- and T-cell homeostasis and reduced immune repertoire diversity. The Journal of Allergy and Clinical Immunology. 2013

[124] Nowak-Wegrzyn A, Crawford TO, Winkelstein JA, Carson KA, Lederman HM. Immunodeficiency and infections in ataxia-telangiectasia. Journal of Pediatrics. 2004

[125] Bassing CH, Swat W, Alt FW. The mechanism and regulation of

chromosomal V[D]J recombination. Cell. 2002

[126] Ghiasy S, Parvaneh L, Azizi G, Sadri G, Zaki dizaji M, Abolhassani H, et al. The clinical significance of complete class switching defect in Ataxia telangiectasia patients. Expert Review of Clinical Immunology. 2017

[127] Kraus M, Lev A, Simon AJ, Levran I, Nissenkorn A, Levi YB, et al. Disturbed B and T cell homeostasis and neogenesis in patients with ataxia telangiectasia. Journal of Clinical Immunology. 2014

[128] Bredemeyer AL, Huang C-Y, Walker LM, Bassing CH, Sleckman BP. Aberrant V[D]J recombination in ataxia telangiectasia mutateddeficient lymphocytes is dependent on nonhomologous DNA end joining. Journal of Immunology. 2008

[129] Rodier F, Coppé JP, Patil CK, Hoeijmakers WAM, Muñoz DP, Raza SR, et al. Persistent DNA damage signalling triggers senescenceassociated inflammatory cytokine secretion. Nature Cell Biology. 2009

[130] Rodier F, Munoz DP, Teachenor R, Chu V, Le O, Bhaumik D, et al. DNA-SCARS: Distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion. Journal of Cell Science. 2011

[131] Fakhoury M. Role of immunity and inflammation in the pathophysiology of neurodegenerative diseases. Neurodegenerative Diseases. 2015

[132] Estiar MA, Mehdipour P. ATM in breast and brain tumors: A comprehensive review. Cancer Biology & Medicine. 2018

[133] Nussenzweig A, Nussenzweig MC. Origin of chromosomal translocations in lymphoid cancer. Cell. 2010

[134] Lange J, Pan J, Cole F, Thelen MP, Jasin M, Keeney S. ATM controls meiotic double-strand-break formation. Nature. 2011

[135] Hamer G, Kal HB, Westphal CH, Ashley T, de Rooij DG. Ataxia telangiectasia mutated expression and activation in the Testis1. Biology of Reproduction. 2004

[136] Macaulay VM, Salisbury AJ, Bohula EA, Playford MP, Smorodinsky NI, Shiloh Y. Downregulation of the type 1 insulin-like growth factor receptor in mouse melanoma cells is associated with enhanced radiosensitivity and impaired activation of ATM kinase. Oncogene. 2001

[137] Ching JK, Luebbert SH, Collins RL IV, Zhang Z, Marupudi N, Banerjee S, et al. Ataxia telangiectasia mutated impacts insulin-like growth factor 1 signalling in skeletal muscle. Experimental Physiology. 2013

Section 4

Reading and

Neurodevelopmental Disorder

87

Section 4
